Drawing for Serial No. 79211584

USPTO serial 79211584

Serial No. 79211584

Reviewed by CopyMark Law Group

Reg. 5466716Status 739Registered
Filing date
Status date
Registration date
May 15, 2018
Examiner
MESSICK, TABITHA LEE
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with Serial No. 79211584?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Emily A. Bayton

Emily A. Bayton FAEGRE DRINKER BIDDLE & REATH LLP1144 15th Street, Suite 3400Denver, CO 80202United States

Goods and services

ClassDescriptionStatusFirst use
003Non-medicated skin care and skin protection preparations and substances; adhesive removerACTIVE—
005Pharmaceutical preparations and substances for protection and care of the skin; pharmaceutical preparations and substances for the treatment of skin disorders; pharmaceutical preparations and substances for the treatment of wounds; medical plasters and medical dressings; Medical bandages for skin wounds, surgical bandages and medical dressings for wound care; medical preparations in the nature of wound filling material for debridement and cavity filling, namely, paste, powder, alginate, gel and granulate; medical adhesive plaster; medical adhesive tape; medical absorbent tape; medical adhesive elastic tape; medical mouldable paste for filling skin folds and creases to avoid leakage of output from stoma appliances; pharmaceutical preparations for skin care, namely, protective skin barrier lotion for medical use, protective skin barrier cream for medical use, protective skin barrier paste for medical use and protective skin barrier film for medical use; lubricating deodorant for stoma pouches for medical purposes; deodorizers for ostomy bags for medical use; wound cleanser for medical use; room deodorant; pharmaceutical preparations, namely, anti-septic hand cleanser; biological implants, namely, a vital processed human connective tissue; shampoo and body wash, medicatedACTIVE—
009Computer application software for mobile phones, tablets and other similar instruments, namely, software for accessing healthcare information in the field of ostomy, continence, urology, wound and skin care assessment, treatment and management; software for computer applications for accessing information on parking lots with wheelchair toiletsACTIVE—
010Medical instruments and apparatus for use in general surgery and surgical instruments and apparatus; medical and surgical apparatus and instruments for the surgical and medical treatment of ostomy and incontinence; medical and surgical instruments and apparatus for the medical and surgical treatment of the urinary tract system and for pelvic floor reconstruction; urology instruments and apparatus for medical examination and treatment; gynecology instruments and apparatus for medical examination and treatment; instruments and apparatus for the medical and surgical treatment of wounds; surgical and medical devices in the form of stimulating apparatus for the rehabilitation of muscles; ostomy bags for medical use; urine bags for medical use; envelopes and receptacles for the collection of excretions from the human body for medical use; medical ostomy appliance odour filters; catheters; irrigators and their parts and fitting in the form of drainage tubes, pumps, sleeves, bags and regulators for medical purposes; medical instruments in the nature of suction and rinse instruments for [ laparascopy ] * laparoscopy * ; medical probes; condom catheters in the nature of urine condoms, urisheaths; ostomy belts for medical use; anal plugs for medical use; stents; medical guidewires; medical apparatus, namely, ureteral access sheaths; needles for medical use in the nature of biopsy needles; injection needles; surgical urology dilators; medical instruments and apparatus, namely, kidney stone extractors; testicular and penile prostheses; surgical implants comprising artificial material; urethral slings; elastic bandages, supportive bandages, orthopedic support bandages; artificial limbs; suture material; anti-microbial medical textile for medical use in the nature of moisture wicking synthetic fabric for management of complications associated with skin foldsACTIVE—
016Magazines featuring topics on management and care in the field of ostomy, continence, urology, wound and skin care; printed matter in the nature of newsletters, leaflets, booklets, displays and posters in the field of ostomy, continence, urology, wound and skin care; printed instructional material in the field of ostomy, continence, urology, wound and skin care; printed teaching material not including apparatus in the field of ostomy, continence, urology, wound and skin careACTIVE—
041Education services, namely, online and telephone coaching for patients in the field of ostomy, continence, urology, wound and skin care; providing of training in the nature of conducting of workshops and seminars in the field of ostomy, continence, urology, wound and skin careACTIVE—
042Scientific research services for others in the field of health careACTIVE—
044Health care services, namely, providing medical information in the field of ostomy, continence, urology, wound and skin careACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 4, 2024NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Dec 4, 2024C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Dec 2, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 23, 2024ES75TEAS SECTION 71 & 15 RECEIVED—
Jun 28, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 28, 2023ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jun 28, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 28, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 28, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 28, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 15, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Dec 3, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 3, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 5, 2018CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Oct 5, 2018COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Sep 28, 2018CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Sep 15, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 23, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 23, 2018FIMPFINAL DISPOSITION PROCESSED—
Aug 15, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 15, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 9, 2018GPNXNOTIFICATION PROCESSED BY IB—
Feb 27, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 27, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 21, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 21, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 7, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 25, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 25, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Jan 25, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 25, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 25, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 24, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Jan 24, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 24, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 24, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 9, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 9, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 5, 2018ALIEASSIGNED TO LIE—
Dec 20, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 20, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 4, 2017RFNTREFUSAL PROCESSED BY IB—
Jul 19, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 19, 2017RFRRREFUSAL PROCESSED BY MPU—
Jul 13, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 12, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 12, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 8, 2017DOCKASSIGNED TO EXAMINER—
Jul 8, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 6, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance